BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 32532213)

  • 21. Self-reported medication in community-dwelling older adults in Germany: results from the Berlin Initiative Study.
    Mielke N; Huscher D; Douros A; Ebert N; Gaedeke J; van der Giet M; Kuhlmann MK; Martus P; Schaeffner E
    BMC Geriatr; 2020 Jan; 20(1):22. PubMed ID: 31964342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polypharmacy and specific comorbidities in university primary care settings.
    Aubert CE; Streit S; Da Costa BR; Collet TH; Cornuz J; Gaspoz JM; Bauer D; Aujesky D; Rodondi N
    Eur J Intern Med; 2016 Nov; 35():35-42. PubMed ID: 27289492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and internal validation of prognostic models to predict negative health outcomes in older patients with multimorbidity and polypharmacy in general practice.
    Müller BS; Uhlmann L; Ihle P; Stock C; von Buedingen F; Beyer M; Gerlach FM; Perera R; Valderas JM; Glasziou P; van den Akker M; Muth C
    BMJ Open; 2020 Oct; 10(10):e039747. PubMed ID: 33093036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late-life depression and the association with multimorbidity and polypharmacy: a cross-sectional study.
    Holvast F; van Hattem BA; Sinnige J; Schellevis F; Taxis K; Burger H; Verhaak PFM
    Fam Pract; 2017 Sep; 34(5):539-545. PubMed ID: 28369380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care. MULTIPAP Study.
    Lozano-Hernández CM; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; Barrio-Cortes J; Gimeno-Feliu LA; Poblador-Plou B; Cura-González ID;
    PLoS One; 2020; 15(6):e0235148. PubMed ID: 32579616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study.
    Nguyen TN; Ngangue P; Haggerty J; Bouhali T; Fortin M
    Fam Pract; 2019 Nov; 36(6):706-712. PubMed ID: 31104072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of multimorbidity and polypharmacy among cancer survivors: a population-based nested case-control study.
    Keats MR; Cui Y; DeClercq V; Grandy SA; Sweeney E; Dummer TJB
    Support Care Cancer; 2021 Feb; 29(2):713-723. PubMed ID: 32444894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis.
    Guisado-Clavero M; Roso-Llorach A; López-Jimenez T; Pons-Vigués M; Foguet-Boreu Q; Muñoz MA; Violán C
    BMC Geriatr; 2018 Jan; 18(1):16. PubMed ID: 29338690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese population.
    Aoki T; Yamamoto Y; Ikenoue T; Onishi Y; Fukuhara S
    Sci Rep; 2018 Feb; 8(1):3806. PubMed ID: 29491441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soft clustering using real-world data for the identification of multimorbidity patterns in an elderly population: cross-sectional study in a Mediterranean population.
    Violán C; Foguet-Boreu Q; Fernández-Bertolín S; Guisado-Clavero M; Cabrera-Bean M; Formiga F; Valderas JM; Roso-Llorach A
    BMJ Open; 2019 Aug; 9(8):e029594. PubMed ID: 31471439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in Multimorbidity and Polypharmacy Patterns in Young and Adult Population over a 4-Year Period: A 2011-2015 Comparison Using Real-World Data.
    Mucherino S; Gimeno-Miguel A; Carmona-Pirez J; Gonzalez-Rubio F; Ioakeim-Skoufa I; Moreno-Juste A; Orlando V; Aza-Pascual-Salcedo M; Poblador-Plou B; Menditto E; Prados-Torres A
    Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33919351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
    Jungo KT; Streit S; Lauffenburger JC
    BMC Geriatr; 2021 Mar; 21(1):163. PubMed ID: 33676398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
    Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
    PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimorbidity and Polypharmacy Are Independently Associated With Mortality in Older People With Intellectual Disabilities: A 5-Year Follow-Up From the HA-ID Study.
    Schoufour JD; Oppewal A; van der Maarl HJK; Hermans H; Evenhuis HM; Hilgenkamp TIM; Festen DA
    Am J Intellect Dev Disabil; 2018 Jan; 123(1):72-82. PubMed ID: 29281324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study.
    Zhao Y; Wang J; Zhu X; Zhang X; Zhang Y; Zhang W; Dong Y
    BMC Geriatr; 2023 Jul; 23(1):423. PubMed ID: 37434147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multimorbidity as a predictor of health service utilization in primary care: a registry-based study of the Catalan population.
    Monterde D; Vela E; Clèries M; Garcia-Eroles L; Roca J; Pérez-Sust P
    BMC Fam Pract; 2020 Feb; 21(1):39. PubMed ID: 32066377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in multimorbidity and polypharmacy trends: A repeated cross-sectional study of older adults in Ontario, Canada.
    Maxwell CJ; Mondor L; Pefoyo Koné AJ; Hogan DB; Wodchis WP
    PLoS One; 2021; 16(4):e0250567. PubMed ID: 33901232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Life-course socioeconomic conditions, multimorbidity and polypharmacy in older adults: A retrospective cohort study.
    Jungo KT; Cheval B; Sieber S; Antonia van der Linden BW; Ihle A; Carmeli C; Chiolero A; Streit S; Cullati S
    PLoS One; 2022; 17(8):e0271298. PubMed ID: 35917337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting poorer health outcomes in older community-dwelling patients with multimorbidity: prospective cohort study assessing the accuracy of different multimorbidity definitions.
    Sasseville M; Smith SM; Freyne L; McDowell R; Boland F; Fortin M; Wallace E
    BMJ Open; 2019 Jan; 9(1):e023919. PubMed ID: 30612111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.